GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-cov-2 3CL in complex with inhibitor NK01-63

Analyse Crystal structure of SARS-cov-2 3CL in complex with inhibitor NK01-63 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7TIZ
Type
protein
Length
303 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase NSP5
EC
3.4.22.69
UniProt
P0DTC1
Ligands
N63, NA, SCN
Pockets
2 · best druggability 0.53

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase NSP5 (EC 3.4.22.69)protein30326% helix, 29% strandP0DTC1

Ligands and binding sites

  • N63 · (1S,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-{[N-({[3-(trifluoromethyl)phenyl]methoxy}carbonyl)-L-leucyl]amino}propane-1-sulfonic acid · ligand · chains A
  • NA · Sodium ion · metal · chains A
  • SCN · Thiocyanate ion · ion · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11790.530.7928N63, SCN
2660.290.7414empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7TIZ · Crystal structure of SARS-CoV-2 3CL in complex with inhibitor NK01-63 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.